[go: up one dir, main page]

BRPI0911083A2 - métodos para o tratamento ou prenvenção de diabetes mullitus e outros desequilíbrios metabólicos - Google Patents

métodos para o tratamento ou prenvenção de diabetes mullitus e outros desequilíbrios metabólicos

Info

Publication number
BRPI0911083A2
BRPI0911083A2 BRPI0911083A BRPI0911083A BRPI0911083A2 BR PI0911083 A2 BRPI0911083 A2 BR PI0911083A2 BR PI0911083 A BRPI0911083 A BR PI0911083A BR PI0911083 A BRPI0911083 A BR PI0911083A BR PI0911083 A2 BRPI0911083 A2 BR PI0911083A2
Authority
BR
Brazil
Prior art keywords
mullitus
diabetes
prevention
treatment
methods
Prior art date
Application number
BRPI0911083A
Other languages
English (en)
Inventor
Kalyanna Sundram
Kenneth C Hayes
Ravigadevi Sambanthamurthi
Yew Ai Tan
Original Assignee
Univ Brandeis
Malaysian Palm Oil Board
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Brandeis, Malaysian Palm Oil Board filed Critical Univ Brandeis
Publication of BRPI0911083A2 publication Critical patent/BRPI0911083A2/pt
Publication of BRPI0911083A8 publication Critical patent/BRPI0911083A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BRPI0911083A 2008-04-02 2009-04-02 métodos para o tratamento ou prevenção da diabetes mellitus e outros desequilíbrios metabólicos BRPI0911083A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/080,361 US8071143B2 (en) 2008-04-02 2008-04-02 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances
PCT/US2009/039296 WO2009146102A1 (en) 2008-04-02 2009-04-02 Methods for the treatment or prevention of diabetes mellitus and other metabolic imbalances

Publications (2)

Publication Number Publication Date
BRPI0911083A2 true BRPI0911083A2 (pt) 2015-10-06
BRPI0911083A8 BRPI0911083A8 (pt) 2018-08-28

Family

ID=41133491

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911083A BRPI0911083A8 (pt) 2008-04-02 2009-04-02 métodos para o tratamento ou prevenção da diabetes mellitus e outros desequilíbrios metabólicos

Country Status (11)

Country Link
US (2) US8071143B2 (pt)
EP (1) EP2288364B1 (pt)
JP (3) JP2011518131A (pt)
CN (1) CN102088988B (pt)
AU (1) AU2009251568B2 (pt)
BR (1) BRPI0911083A8 (pt)
DK (1) DK2288364T3 (pt)
ES (1) ES2474726T3 (pt)
MY (1) MY153112A (pt)
PL (1) PL2288364T3 (pt)
WO (1) WO2009146102A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY161839A (en) * 2009-05-18 2017-05-15 Malaysian Palm Oil Board A composition for use in the prevention and treatment of cardiovascular diseases
MY173655A (en) 2009-06-09 2020-02-14 Malaysian Palm Oil Board Composition and method for improving vascular health
MY185582A (en) * 2010-01-07 2021-05-24 Malaysian Palm Oil Board Anti-obesity and anti-dyslipidemic effects of oil palm phenolics in preventing atheroslerosis and cardiovascular disease
CN101982115A (zh) * 2010-10-14 2011-03-02 张丽娜 一种防治糖尿病慢性糖中毒的组合物
MY175348A (en) 2011-02-11 2020-06-22 Crea Roberto Treatment of elaeis fruit products with antioxidants
US20150030710A1 (en) * 2011-05-18 2015-01-29 Malaysian Palm Oil Board Compositions comprising extracts or materials derived from palm oil vegetation liquor for inhibition of vision loss due to angiogenesis and method of preparation there
EP2709643B1 (en) * 2011-05-18 2018-05-16 Malaysian Palm Oil Board Compositions comprising extracts or materials derived from palm oil vegetation liguor for inhibition of vision loss due to macular degeneration
CA2857374A1 (en) 2011-09-02 2013-03-07 The Trustees Of Columbia University In The City Of New York Camkii, ip3r, calcineurin, p38 and mk2/3 inhibitors to treat metabolic disturbances of obesity
MY179036A (en) * 2012-12-13 2020-10-26 Malaysian Palm Oil Board Anti-proliferative effects of palm vegetation liquor and extracts thereof in preventing pancreatic cancer
JP6603133B2 (ja) * 2013-02-06 2019-11-06 ブランダイス ユニバーシティー ヤシ果実を用いたｄｎａ損傷およびミトコンドリア機能障害の治療
JP6958922B2 (ja) * 2016-06-13 2021-11-02 シニュークス インターナショナル（タイワン）コーポレイション 安息香酸ナトリウムの共結晶及びその使用
CA3027300C (en) * 2016-06-13 2023-08-08 Syneurx International (Taiwan) Corp. Co-crystals of lithium benzoate and uses thereof
CN108355034A (zh) * 2018-05-02 2018-08-03 黑龙江中医药大学 一种用于治疗多囊卵巢综合征着床障碍的中药制剂及其制备方法
CN109172712A (zh) * 2018-10-09 2019-01-11 昆明理工大学 棕榈果提取物的用途
CN109464561A (zh) * 2018-10-09 2019-03-15 昆明理工大学 棕榈果提取物的用途
MX2024003498A (es) * 2021-09-23 2024-05-28 Rachel Alkalay Composiciones y métodos para tratar o prevenir enfermedades inflamatorias que incluyen diabetes y enfermedades tiroideas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2556897A (en) * 1996-04-12 1997-11-07 Beth Israel Deaconess Medical Center Diabetic supplement bar
MY134878A (en) 1998-09-24 2007-12-31 Palm Oil Res And Dev Board Treatment of liquors derived from oil-bearing fruit.
US6881854B2 (en) 2001-03-29 2005-04-19 Basf Aktiengesellschaft Conjugated unsaturated glyceride mixtures and a method for producing the same
JP4324335B2 (ja) * 2001-09-07 2009-09-02 花王株式会社 カテキン含有飲料
JP2003095942A (ja) * 2001-09-21 2003-04-03 Ito En Ltd 脂肪細胞におけるグルコース取込阻害剤及びｇｌｕｔ４トランスロケーション抑制剤、筋肉細胞におけるグルコース取込活性化剤並びに脂肪軽減飲食物
EP1868454B1 (en) * 2005-04-06 2013-03-06 Nestec S.A. Composition for nutritionally improving glucose control and insulin action

Also Published As

Publication number Publication date
US20120114775A1 (en) 2012-05-10
MY153112A (en) 2014-12-31
PL2288364T3 (pl) 2014-08-29
EP2288364A1 (en) 2011-03-02
AU2009251568A1 (en) 2009-12-03
DK2288364T3 (da) 2014-05-26
CN102088988A (zh) 2011-06-08
US20090252817A1 (en) 2009-10-08
BRPI0911083A8 (pt) 2018-08-28
EP2288364A4 (en) 2011-06-01
JP2014193930A (ja) 2014-10-09
WO2009146102A1 (en) 2009-12-03
US8071143B2 (en) 2011-12-06
CN102088988B (zh) 2013-05-29
JP2017186354A (ja) 2017-10-12
JP6421961B2 (ja) 2018-11-14
ES2474726T3 (es) 2014-07-09
EP2288364B1 (en) 2014-03-26
AU2009251568B2 (en) 2014-08-14
US9326957B2 (en) 2016-05-03
JP2011518131A (ja) 2011-06-23

Similar Documents

Publication Publication Date Title
BRPI0911083A2 (pt) métodos para o tratamento ou prenvenção de diabetes mullitus e outros desequilíbrios metabólicos
BRPI0919288A2 (pt) teriapia de combinação para tratamento de diabetes e condições relacionadas.
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0921237A2 (pt) métodos e composições para o tratamento de distúrbios associados ao complemento
BRPI0915282A2 (pt) agonistas mistos baseados no gip para o tratamento de distúrbios metabólicos e obesidade
PT2796457T (pt) Genz 112638 para o tratamento de doença de gaucher ou de fabry em terapia de associação
BRPI0911923A2 (pt) dispositivos filamentosos para o tratamento de defeitos vasculares
PT2367561E (pt) Composições e métodos para o tratamento da doença celíaca
HUE049880T2 (hu) Anyag és eljárások Her-3-mal összefüggõ betegségek kezelésére vagy megelõzésére
HRP20171012T1 (hr) Fungicidni pripravak i postupak za suzbijanje štetnih gljiva
BRPI1013705A2 (pt) compostos, composição farmacêutica, método de tratamento de doença ou condição associada com função de trap1 e usos de compostos e de composição farmacêutica
BRPI0815588A2 (pt) Compostos de poliorganossiloxano-poliuréia e/ou de poliorganossilo-xano-poliuretano
PT2240137T (pt) Aparelho para o tratamento da obesidade
BRPI0906549A2 (pt) Bandagens médicas com válvulas e kits contendo as mesmas.
BRPI0917130A2 (pt) biomarcadores para tratamento anti-tnf de colite ulcerativa e transtornos relacionados
BRPI0817298A2 (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
BRPI0908154A2 (pt) Métodos para o tratamento e a prevenção de disfunções retinianas relacionadas à idade
HUE045367T2 (hu) Kombinált terápia diabétesz kezelésére
BRPI0919759A2 (pt) polipeptídeos para tratamento e prevenção de adesões
BRPI1006145A2 (pt) "composição e método para tratamento de diabetes".
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
BRPI0819105A2 (pt) composição para o tratamento e prevenção de edema de pálpebra
BRPI1009783A2 (pt) compostos para o tratamento de distúrbios metabólicos.
BRPI0817974A2 (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07B Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 7.1 NA RPI NO 2611 DE 19/01/2021 POR TER SIDO INDEVIDA.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time